Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Y Y Fong

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 28, 2018
Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic VariabilityZaril H Zakaria, Alan Y Y Fong, Raj K S Badhan
European Heart Journal|February 22, 2012
Asia's heart for diversityWan A Wan Ahmad, Alan Y Y Fong, David K L Quek, et al.
The American Journal of Cardiology|February 19, 2013
Impact of cardiac care variation on ST-elevation myocardial infarction outcomes in MalaysiaSharmini Selvarajah, Alan Y Y Fong, Gunavathy Selvaraj, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 28, 2021
Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trialsRuth Sim, Chun Wie Chong, Navin K Loganadan, et al.
Clinical Cardiology|July 19, 2019
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradoxIngo Ahrens, Oleg Averkov, Eduardo C Zúñiga, et al.
International Journal of Cardiology|October 11, 2022
Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaborationMark Y Z Wong, Jonathan J L Yap, Hui Jun Chih, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Subclinical coronary artery disease in Asian rheumatoid arthritis patients who were in remission: a pilot studyN Hanim Ma, C L Teh, A Rapaee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|July 28, 2018
Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic VariabilityZaril H Zakaria, Alan Y Y Fong, Raj K S Badhan
European Heart Journal|February 22, 2012
Asia's heart for diversityWan A Wan Ahmad, Alan Y Y Fong, David K L Quek, et al.
The American Journal of Cardiology|February 19, 2013
Impact of cardiac care variation on ST-elevation myocardial infarction outcomes in MalaysiaSharmini Selvarajah, Alan Y Y Fong, Gunavathy Selvaraj, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 28, 2021
Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trialsRuth Sim, Chun Wie Chong, Navin K Loganadan, et al.
Clinical Cardiology|July 19, 2019
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradoxIngo Ahrens, Oleg Averkov, Eduardo C Zúñiga, et al.
International Journal of Cardiology|October 11, 2022
Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaborationMark Y Z Wong, Jonathan J L Yap, Hui Jun Chih, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Subclinical coronary artery disease in Asian rheumatoid arthritis patients who were in remission: a pilot studyN Hanim Ma, C L Teh, A Rapaee, et al.
Pageof 1